Nantahala Capital Management »

Journey Med Corp shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Journey Med Corp (DERM) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Journey Med Corp

Tip: Access up to 7 years of quarterly data

All positions including Journey Med Corp held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Journey Med Corp by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $955k 349k 2.74
2023-06-30 $284k 179k 1.59
2023-03-31 $333k 212k 1.57
2022-12-31 $434k 226k 1.92

More positions owned by Nantahala Capital Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Russell 2000 Etf (IWM)
Soleno Therapeutics (SLNO)
Soleno Therapeutics (SLNO)
Establishment Labs Holdings Ord (ESTA)
Establishment Labs Holdings Ord (ESTA)
Meta Financial (CASH)
Meta Financial (CASH)
Costco Wholesale Corporation Put Option (COST)
Costco Wholesale Corporation Put Option (COST)
Imax Corp Cad (IMAX)
Imax Corp Cad (IMAX)
Hilton Grand Vacations (HGV)

View all positions for Nantahala Capital Management

Top funds holding Journey Med Corp

American Financial Group
Vanguard Group
Neuberger Berman Group
Millennium Management
Perkins Capital Management
Jane Street
Virtu Financial
Cubist Systematic Strategies
Walleye Trading Advisors
Man Group
UBS Group
Creative Planning
Citadel Advisors
Allegiance Financial Group Advisory Services
Advisor Group Holdings

View all funds holding Journey Med Corp